Thrombin signalling and protease-activated receptors

@article{Coughlin2000ThrombinSA,
  title={Thrombin signalling and protease-activated receptors},
  author={Shaun R Coughlin},
  journal={Nature},
  year={2000},
  volume={407},
  pages={258-264}
}
How does the coagulation protease thrombin regulate cellular behaviour? The protease-activated receptors (PARs) provide one answer. In concert with the coagulation cascade, these receptors provide an elegant mechanism linking mechanical information in the form of tissue injury or vascular leakage to cellular responses. Roles for PARs are beginning to emerge in haemostasis and thrombosis, inflammation, and perhaps even blood vessel development. 
Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculature.
TLDR
Thrombin is the ultimate protease in the coagulation cascade whose pleiotropic actions can lead to thrombosis after tissue injury and conversion to fibrin, which is essential for laying the meshwork for clot formation. Expand
Protease-activated receptors in vascular biology.
  • S. Coughlin
  • Biology, Medicine
  • Thrombosis and haemostasis
  • 2001
TLDR
The current understanding of the role of PARs in platelet and endothelial cell activation and their potential importance in normal and disease states is discussed. Expand
Orchestration of coagulation protease signaling by tissue factor.
TLDR
Targeting inflammatory cell signaling events of the coagulation system may become an important aspect of efforts to improve antithrombotic therapy. Expand
Tissue factor, protease activated receptors and pathologic heart remodelling.
TLDR
The role of tissue factor, coagulation proteases and protease activated receptors in heart haemostasis and the pathological heart remodelling associated with myocardial infarction, viral myocarditis and hypertension is focused on. Expand
Science review: Role of coagulation protease cascades in sepsis
TLDR
Activation of the coagulation cascade and the downstream endothelial cell localized anticoagulant pathway thus have opposing effects on systemic inflammation, and this dichotomy is of relevance for the interpretation of preclinical and clinical data that document nonuniform responses to anticoAGulant strategies in sepsis therapy. Expand
COAGULATION CASCADE | Thrombin
Thrombin is a serine protease that plays a central role in hemostasis by promoting blood coagulation. It is formed from its precursor, prothrombin, following tissue injury and converts fibrinogen toExpand
Protease receptor antagonism to target blood platelet therapies
TLDR
This review focuses on current antiplatelet therapies as well as innovative approaches to targeting PARs in patients with atherothrombotic vascular disease. Expand
Thrombin as a Regulator of Inflammation and Reparative Processes in Tissues
TLDR
Mechanisms of regulatory effects of thrombin on mast cells associated with nitric oxide release are discussed and functions involved in its interaction with PAR family receptors, activation of platelets, endothelial cells, leukocytes, smooth muscle cells, and mast cells are reviewed. Expand
Protease-activated receptor 2 signaling in inflammation
TLDR
The roles of PAR2 are reviewed with an emphasis on the role of coagulation and other extracellular protease pathways that cleave PAR2 in epithelial, immune, and neuronal cells to regulate physiological and pathophysiological processes. Expand
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
  • S. Coughlin
  • Biology, Medicine
  • Journal of thrombosis and haemostasis : JTH
  • 2005
TLDR
Roles for PARs in blood vessel formation and other processes during embryonic development are emerging, and whether these reflect new roles for the coagulation cascade and/or PAR signaling to other proteases remains to be explored. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 66 REFERENCES
Protease-activated receptor 3 is a second thrombin receptor in humans
TLDR
Cl cloning and characterization of a new human thrombin receptor, designated protease-activated receptor 3 (PAR3) is reported, which can mediate throm-bin-triggered phosphoinositide hydrolysis and is expressed in a variety of tissues, making it a candidate for the sought-after second platelet throm bin receptor. Expand
Inflammation, sepsis, and coagulation.
TLDR
Current studies seek to identify the substrate for the APC-EPCR complex as the next step in elucidating the mechanisms by which the protein C pathway modulates the response to injury and inflammation. Expand
How the protease thrombin talks to cells.
  • S. Coughlin
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1999
TLDR
Four PARs have now been identified and cells have evolved a trafficking solution to the signaling problem presented by PARs, which is critical for termination of thrombin signaling. Expand
Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions.
TLDR
Observations in models of flow and in vivo support the original experiments that indicated that PAF acts at this vascular interface and may be a critical determinant in its roles in physiologic and pathologic responses. Expand
Role of the thrombin receptor in development and evidence for a second receptor
TLDR
It is shown that although disruption of the thrombin receptor (tr) gene in mice causes about half of the tr-/- embryos to die at embryonic day 9–10, half survive to become grossly normal adult mice with no bleeding diathesis. Expand
PAR3 is a cofactor for PAR4 activation by thrombin
Identification of the mechanisms by which the coagulation protease thrombin activates platelets is critical for understanding haemostasis and thrombosis. Thrombin activates cells at least in part byExpand
Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling.
TLDR
Surprisingly, this shut off occurred despite the continued presence of cleaved and "activated" receptors on the cell surface and at a time when the cells were refractory to thrombin but sensitive to agonist peptide, suggesting that a novel shut off mechanism may have evolved to deal with the tethered ligand. Expand
Cathepsin G Activates Protease-activated Receptor-4 in Human Platelets*
TLDR
Data show that PAR4 mediates platelet responses to cathepsin G and support the hypothesis that cathePSin G might mediate neutrophil-platelet interactions at sites of vascular injury or inflammation. Expand
A dual thrombin receptor system for platelet activation
TLDR
It is reported that thrombin responses in platelets from PAR3-deficient mice were markedly delayed and diminished but not absent, and the identification of a two-receptor system for platelet activation byThrombin has important implications for the development of antithrombotic therapies. Expand
Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.
TLDR
This study demonstrates that the cloned platelet thrombin receptor is necessary for platelet activation by thrombosis, and provides a strategy for developing blocking monoclonal antibodies of potential therapeutic value. Expand
...
1
2
3
4
5
...